The Association of Lipid-Modifying Medications With Mortality in Patients on Long-Term Peritoneal Dialysis  Alexander S. Goldfarb-Rumyantzev, MD, PhD,

Slides:



Advertisements
Similar presentations
The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Advertisements

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Renal Function Testing
Peritoneal dialysis American Journal of Kidney Diseases
Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes  Eduardo Lacson, MD, MPH, Weiling Wang,
Citrate Plasma Levels in Patients Under Regional Anticoagulation in Continuous Venovenous Hemofiltration  Gerd R. Hetzel, MD, Gediz Taskaya, Christoph.
Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Kostas C. Siamopoulos, MD, FRSH, Chariklia Gouva, MD, Konstantinos P
The US Renal Data System “Pie Chart of Death”
Cardiovascular Disease and CKD: Core Curriculum 2010
Impact of Comorbidities on Mortality in Managed Care Patients With CKD
Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective  J. Michael Lazarus, MD, Raymond M. Hakim,
Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study  Rebecca A. Spicer, MBChB, Philip A. Clayton,
Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study  Digsu.
Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial  Hao Yan, MD, Wei Fang, MD,
Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): Nutrition guidelines, indicators, and.
Hung-Bin Tsai, MD, Chia-Ter Chao, MD 
Evaluation of the Potential Living Kidney Donor
Hai-yan Wang, MD, American Journal of Kidney Diseases
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Wayne Trebbin, MD, Peter Monteleone, MD 
Salt and Hypertension American Journal of Kidney Diseases
J-Shaped Mortality Relationship for Uric Acid in CKD
Erratum Regarding “Phosphate Removal With Several Thrice-Weekly Dialysis Methods in Overweight Hemodialysis Patients” [Am J Kidney Dis 2009; 54: ] 
Is There Any Reason to Stent Atherosclerotic Renal Artery Stenosis?
The Use of N-of-1 Trials to Individualize Treatment in Patients With Renal Magnesium Wasting  Anneke P. Bech, MD, Jack F.M. Wetzels, MD, Hans Groenewoud,
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
Geriatrics American Journal of Kidney Diseases
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Usability Testing and Acceptance of an Electronic Medication Inquiry System for CKD Patients  Clarissa J. Diamantidis, MD, MHS, Marni Zuckerman, MA, Wanda.
Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia  Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study  Eric D.
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Salicylate Intoxication as a Cause of Pseudohyperchloremia
Risks and Outcomes of Acute Kidney Injury Requiring Dialysis After Cardiac Transplantation  Janet M. Boyle, MD, Soundous Moualla, MD, Susana Arrigain,
Christina L. Klein, MD, Daniel C. Brennan, MD, FACP 
Prevalence and Severity of Renal Disease in Familial Dysautonomia
Quiz Page April 2008 American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
Survival by time of day of hemodialysis: analysis of United States renal data system dialysis morbidity and mortality waves III/IV  Kevin C Abbott, MD,
Drug Dose Adjustments in Patients With Renal Impairment
Erratum American Journal of Kidney Diseases
Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Risk for Incident Renal Dialysis in a Managed Care Population
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Trial Quality in Nephrology: How Are We Measuring Up?
Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm  David P. Calfee, MD, MS  American Journal of Kidney.
American Journal of Kidney Diseases
Making Music American Journal of Kidney Diseases
Erratum American Journal of Kidney Diseases
The Use of Vaccines in Adult Patients With Renal Disease
In the Literature: Cognitive Impairment in Hemodialysis Patients
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD 
Quiz Page June 2011 American Journal of Kidney Diseases
Dialysis Research and N-of-1 Trials: Made for Each Other?
Quiz Page January 2010 American Journal of Kidney Diseases
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
A Randomized Controlled Trial of Coiled Versus Straight Swan-Neck Tenckhoff Catheters in Peritoneal Dialysis Patients  David W. Johnson, PhD, Jennifer.
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
James A. Sloand, MD, Mark A. Shelly, MD 
Presentation transcript:

The Association of Lipid-Modifying Medications With Mortality in Patients on Long-Term Peritoneal Dialysis  Alexander S. Goldfarb-Rumyantzev, MD, PhD, Arsalan N. Habib, MD, Bradley C. Baird, MS, MStat, Lev L. Barenbaum, PhD, Alfred K. Cheung, MD  American Journal of Kidney Diseases  Volume 50, Issue 5, Pages 791-802 (November 2007) DOI: 10.1053/j.ajkd.2007.07.023 Copyright © 2007 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Flow chart describing study subject selection from the US Renal Data System (USRDS) Dialysis Morbidity and Mortality (DMMS) Wave 2 file. American Journal of Kidney Diseases 2007 50, 791-802DOI: (10.1053/j.ajkd.2007.07.023) Copyright © 2007 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Kaplan-Meier curves show the association between use of lipid-modifying medications and (A) all-cause and (B) cardiovascular mortality. American Journal of Kidney Diseases 2007 50, 791-802DOI: (10.1053/j.ajkd.2007.07.023) Copyright © 2007 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Adjusted hazard ratios for all-cause mortality associated with the use of lipid-modifying medications in subgroups of patients defined by serum total cholesterol level. The plot suggests an incremental increase in the benefit of using lipid-modifying medications with increasing cholesterol levels. To convert total cholesterol in mg/dL to mmol/L, multiply by 0.0259. American Journal of Kidney Diseases 2007 50, 791-802DOI: (10.1053/j.ajkd.2007.07.023) Copyright © 2007 National Kidney Foundation, Inc. Terms and Conditions

Figure 4 Adjusted hazard ratios for all-cause (filled bars) and cardiovascular (striped bars) mortality associated with use of lipid-modifying medications in the entire study population and the diabetic subgroup. *Statistically significant (P < 0.05) difference compared with patients not using these medications (open bar). American Journal of Kidney Diseases 2007 50, 791-802DOI: (10.1053/j.ajkd.2007.07.023) Copyright © 2007 National Kidney Foundation, Inc. Terms and Conditions